breast carcinomas.
A comprehensive morphological study for basal-like breast carcinomas with comparison to nonbasal-like carcinomas
11
Immunohistochemical analysis of medullary breast carcinoma autoantigens in different histological types of breast carcinomas
11
Clinico-Pathological Study of Breast Carcinomas with ER, PR Studies.
109
Original Article Phosphorylated mTOR expression correlates with poor outcome in early-stage triple negative breast carcinomas
8
Primary neuroendocrine breast carcinomas: a retrospective analysis and review of literature
11
Estrogenic microenvironment generated by organochlorine residues in adipose mammary tissue modulates biomarker expression in ERα-positive breast carcinomas
9
LIN7A is a major determinant of cell polarity defects in breast carcinomas
10
Estrogenic microenvironment generated by organochlorine residues in adipose mammary tissue modulates biomarker expression in ERα positive breast carcinomas
9
FGFR1 amplification in breast carcinomas: a chromogenic in situhybridisation analysis
12
Quantification of Microvessel Density in Breast Carcinomas Based on Immunohistochemistry
147
Cultural and Environmental Factors of Triple-Negative Breast Carcinomas
11
Breast carcinomas: variations in sonoelastographic appearance
9
Estrogen receptor alpha (ERα/ESR1) mediates the p53- independent overexpression of MDM4/MDMX and MDM2 in human breast cancer
21
Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast
5
BRCA promoter methylation in sporadic versus BRCA germline mutation related breast cancers
13
Role of the Cdc25A phosphatase in human breast cancer
10
Original Article Determination of whole transcription profiles and specific pathways in invasive ductal breast carcinoma
9
Elevated mammaglobin (h MAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumour phenotype
6
No evidence for promoter region methylation of the succinate dehydrogenase and fumarate hydratase tumour suppressor genes in breast cancer
8
Immunotherapy of Cancer—A Historical Note
5